Professor, Laboratory of Microbiology and Experimental Medicine, Department of Zoology, University of Gour Banga, India
*Corresponding Author: Shyamapada Mandal, Professor, Laboratory of Microbiology and Experimental Medicine, Department of Zoology, University of Gour Banga, India.
Received: March 06, 2020; Published: April 01, 2020
In December 2019, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), a novel coronavirus provisionally known as 2019 novel coronavirus (2019-nCoV), has been emerged in Wuhan (Hubei province, China) causing outbreak of COVID-19 (coronavirus disease 2019) . The 2019-nCoV, which is genetically different from two previously reported human-infecting β-coronaviruses: SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (Middle East respiratory syndrome coronavirus), has been considered as a new β-coronavirus and named as SARS-CoV-2 (subgenus: Sarbecovirus) [2,3].
Citation: Shyamapada Mandal. “COVID-19: An Ongoing Global Epidemic of Novel Coronavirus (2019-nCoV/SARS-CoV-2) Infection" Acta Scientific Microbiology 3.5 (2020): 01-02.
Copyright: © 2020 Shyamapada Mandal. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.